ebomi
Colour theme
Sign in
Insider · CIK 0001290166

QVT Associates GP LLC

CIK 0001290166 Name as filed on the most recent filing

Filed as QVT Associates GP LLC (81)

202 transaction lines · from 81 filings · filed 2009-09-24 to 2019-06-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

53 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2010-09-10 P, Open-market purchase Anadys Pharmaceuticals IncANDS 45,000, acquired Open Form 4 filing 0001181431-10-046635
2010-09-01 P, Open-market purchase Anadys Pharmaceuticals IncANDS 43,500, acquired Open Form 4 filing 0001181431-10-045633
2010-08-30 P, Open-market purchase Anadys Pharmaceuticals IncANDS 44,250, acquired Open Form 4 filing 0001181431-10-044955
2010-08-27 P, Open-market purchase Anadys Pharmaceuticals IncANDS 10,500, acquired Open Form 4 filing 0001181431-10-044955
2010-08-26 P, Open-market purchase Anadys Pharmaceuticals IncANDS 27,475, acquired Open Form 4 filing 0001181431-10-044660
2010-08-25 P, Open-market purchase Anadys Pharmaceuticals IncANDS 29,580, acquired Open Form 4 filing 0001181431-10-044660
2010-08-24 P, Open-market purchase Anadys Pharmaceuticals IncANDS 60,377, acquired Open Form 4 filing 0001181431-10-044156
2010-08-23 P, Open-market purchase Anadys Pharmaceuticals IncANDS 48,330, acquired Open Form 4 filing 0001181431-10-044156
2010-08-20 P, Open-market purchase Anadys Pharmaceuticals IncANDS 7,080, acquired Open Form 4 filing 0001181431-10-043180
2010-08-19 P, Open-market purchase Anadys Pharmaceuticals IncANDS 28,640, acquired Open Form 4 filing 0001181431-10-043180
2010-08-17 P, Open-market purchase Anadys Pharmaceuticals IncANDS 9,000, acquired Open Form 4 filing 0001181431-10-042474
2010-08-16 P, Open-market purchase Anadys Pharmaceuticals IncANDS 65,100, acquired Open Form 4 filing 0001181431-10-042474
2010-08-12 P, Open-market purchase Anadys Pharmaceuticals IncANDS 63,050, acquired Open Form 4 filing 0001181431-10-042009
2010-08-03 P, Open-market purchase Anadys Pharmaceuticals IncANDS 100,296, acquired Open Form 4 filing 0001181431-10-040566
2010-07-06 P, Open-market purchase Anadys Pharmaceuticals IncANDS 59,400, acquired Open Form 4 filing 0001181431-10-036968
2010-07-02 P, Open-market purchase Anadys Pharmaceuticals IncANDS 110,192, acquired Open Form 4 filing 0001181431-10-036521
2010-04-07 P, Open-market purchase TPC Group Inc.TPCP 2,479,748, acquired Open Form 4 filing 0001181431-10-020965
2009-12-16 P, Open-market purchase Inhibitex, Inc.INHX 36,550, acquired Open Form 4 filing 0001181431-09-057762
2009-12-11 P, Open-market purchase Inhibitex, Inc.INHX 17,875, acquired Open Form 4 filing 0001181431-09-056797
2009-12-10 P, Open-market purchase Inhibitex, Inc.INHX 54,750, acquired Open Form 4 filing 0001181431-09-056219
2009-12-09 P, Open-market purchase Inhibitex, Inc.INHX 20,470, acquired Open Form 4 filing 0001181431-09-056219
2009-12-07 P, Open-market purchase Inhibitex, Inc.INHX 24,840, acquired Open Form 4 filing 0001181431-09-055809
2009-12-04 P, Open-market purchase Inhibitex, Inc.INHX 20,640, acquired Open Form 4 filing 0001181431-09-055377
2009-12-03 P, Open-market purchase Inhibitex, Inc.INHX 24,750, acquired Open Form 4 filing 0001181431-09-055377
2009-12-02 P, Open-market purchase Inhibitex, Inc.INHX 13,720, acquired Open Form 4 filing 0001181431-09-054897
2009-12-01 P, Open-market purchase Inhibitex, Inc.INHX 49,980, acquired Open Form 4 filing 0001181431-09-054897
2009-11-30 P, Open-market purchase Inhibitex, Inc.INHX 49,500, acquired Open Form 4 filing 0001181431-09-054244
2009-11-27 P, Open-market purchase Inhibitex, Inc.INHX 2 lines 13,728, acquired Open Form 4 filing 0001181431-09-054244
2009-11-25 P, Open-market purchase Inhibitex, Inc.INHX 300, acquired Open Form 4 filing 0001181431-09-053836
2009-11-24 P, Open-market purchase Inhibitex, Inc.INHX 15,966, acquired Open Form 4 filing 0001181431-09-053836
2009-11-23 P, Open-market purchase Inhibitex, Inc.INHX 12,870, acquired Open Form 4 filing 0001181431-09-053404
2009-11-20 P, Open-market purchase Inhibitex, Inc.INHX 11,583, acquired Open Form 4 filing 0001181431-09-053404
2009-11-19 P, Open-market purchase Inhibitex, Inc.INHX 10,780, acquired Open Form 4 filing 0001181431-09-053404
2009-11-18 P, Open-market purchase Inhibitex, Inc.INHX 84,150, acquired Open Form 4 filing 0001181431-09-052873
2009-11-17 P, Open-market purchase Inhibitex, Inc.INHX 9,310, acquired Open Form 4 filing 0001181431-09-052873
2009-11-12 P, Open-market purchase Inhibitex, Inc.INHX 18,810, acquired Open Form 4 filing 0001181431-09-051622
2009-11-11 P, Open-market purchase Inhibitex, Inc.INHX 100,000, acquired Open Form 4 filing 0001181431-09-051622
2009-11-10 P, Open-market purchase Inhibitex, Inc.INHX 13,000, acquired Open Form 4 filing 0001181431-09-050938
2009-11-09 P, Open-market purchase Inhibitex, Inc.INHX 70,290, acquired Open Form 4 filing 0001181431-09-050938
2009-11-06 P, Open-market purchase Inhibitex, Inc.INHX 45,540, acquired Open Form 4 filing 0001181431-09-050537
2009-11-05 P, Open-market purchase Inhibitex, Inc.INHX 47,520, acquired Open Form 4 filing 0001181431-09-050537
2009-11-04 P, Open-market purchase Inhibitex, Inc.INHX 79,000, acquired Open Form 4 filing 0001181431-09-050179
2009-11-03 P, Open-market purchase Inhibitex, Inc.INHX 2 lines 54,450, acquired Open Form 4 filing 0001181431-09-050179
2009-11-02 P, Open-market purchase Inhibitex, Inc.INHX 2 lines 17,253, acquired Open Form 4 filing 0001181431-09-049628
2009-10-30 P, Open-market purchase Inhibitex, Inc.INHX 27,280, acquired Open Form 4 filing 0001181431-09-049628
2009-09-24 S, Open-market sale Pharmasset IncVRUS 2 lines 16,704,000, disposed Open Form 4 filing 0001181431-09-045141

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 17
  • Open-market sale 36
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. QVT Associates GP LLC, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001290166

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.